| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -4.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GANX returned +1.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -37.7% |
| 1 year | +1.8% |
| 5 years | -74.3% |
| All-time high | $14.92 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GANX would be worth today ›No. Gain Therapeutics, Inc. has not paid a dividend in the past 12 months.
Gain Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol GANX.
Gain Therapeutics, Inc. is part of the Healthcare sector.
Gain Therapeutics, Inc. has a market cap of 87.51M USD, based on the latest quote.
